Literature DB >> 3125213

Oxidation of palmitic acid by Mycobacterium leprae in an axenic medium.

S G Franzblau1.   

Abstract

The ability of Mycobacterium leprae to oxidize palmitic acid during incubation in an axenic medium was studied. By using a Buddemeyer-type detection system, partially purified nude-mouse-derived M. leprae was found to produce 14CO2 from 14C-labeled palmitic acid in a linear fashion for at least 1 week. Procedures known to remove residual host tissue did not diminish the rate of 14CO2 evolution, indicating that bacterial metabolism was being measured. Palmitate oxidation was temperature sensitive, with an apparent optimum of 33 degrees C, but pH insensitive. Bacilli exposed to a variety of antileprosy drugs for 1 or 2 weeks displayed significantly reduced rates of 14CO2 evolution upon subsequent addition of 14C-labeled palmitic acid. This activity could be readily detected with 10(6) bacilli, thus indicating its potential for use in clinical susceptibility testing.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3125213      PMCID: PMC266168          DOI: 10.1128/jcm.26.1.18-21.1988

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  16 in total

1.  Rapid radiometric method for determining drug susceptibility of Mycobacterium avium-intracellulare.

Authors:  B G Yangco; E A Eikman; D A Solomon; S C Deresinski; J A Madden
Journal:  Antimicrob Agents Chemother       Date:  1981-04       Impact factor: 5.191

2.  Automatable radiometric detection of growth of Mycobacterium tuberculosis in selective media.

Authors:  G Middlebrook; Z Reggiardo; W D Tigertt
Journal:  Am Rev Respir Dis       Date:  1977-06

3.  Adenosine triphosphate content of Mycobacterium leprae: effect of purification procedures.

Authors:  A M Dhople; E E Storrs
Journal:  Int J Lepr Other Mycobact Dis       Date:  1982-03

4.  Radiometric detection of the metabolic activity of Mycobacterium tuberculosis.

Authors:  D M Cummings; D Ristroph; E E Camargo; S M Larson; H N Wagner
Journal:  J Nucl Med       Date:  1975-12       Impact factor: 10.057

5.  Radiometric estimation of the replication time of bacteria in culture: an objective and precise approach to quantitative microbiology.

Authors:  E U Buddemeyer; G M Wells; R Hutchinson; M D Cooper; G S Johnston
Journal:  J Nucl Med       Date:  1978-06       Impact factor: 10.057

6.  Rapid in vitro metabolic screen for antileprosy compounds.

Authors:  S G Franzblau; R C Hastings
Journal:  Antimicrob Agents Chemother       Date:  1987-05       Impact factor: 5.191

7.  Temperature optimum of Mycobacterium leprae in mice.

Authors:  C C Shepard
Journal:  J Bacteriol       Date:  1965-11       Impact factor: 3.490

8.  Rapid radiometric susceptibility testing of Mycobacterium tuberculosis.

Authors:  J A Kertcher; M F Chen; P Charache; C C Hwangbo; E E Camargo; P A McIntyre; H N Wagner
Journal:  Am Rev Respir Dis       Date:  1978-04

9.  Utilization of palmitic acid by Mycobacterium avium.

Authors:  C McCarthy
Journal:  Infect Immun       Date:  1971-09       Impact factor: 3.441

10.  Superoxide dismutase, peroxidatic activity and catalase in Mycobacterium leprae purified from armadillo liver.

Authors:  P R Wheeler; D Gregory
Journal:  J Gen Microbiol       Date:  1980-12
View more
  30 in total

1.  Activities of various macrolide antibiotics against Mycobacterium leprae infection in mice.

Authors:  R H Gelber; P Siu; M Tsang; L P Murray
Journal:  Antimicrob Agents Chemother       Date:  1991-04       Impact factor: 5.191

2.  Fusidic acid is highly active against extracellular and intracellular Mycobacterium leprae.

Authors:  S G Franzblau; A N Biswas; E B Harris
Journal:  Antimicrob Agents Chemother       Date:  1992-01       Impact factor: 5.191

3.  Quantification of antibiotic drug potency by a two-compartment radioassay of bacterial growth.

Authors:  V Boonkitticharoen; J C Ehrhardt; P T Kirchner
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

4.  Induction of heat shock protein 60 expression in human monocytic cell lines infected with Mycobacterium leprae.

Authors:  K Beimnet; K Söderström; S Jindal; A Grönberg; D Frommel; R Kiessling
Journal:  Infect Immun       Date:  1996-10       Impact factor: 3.441

5.  In vitro and in vivo activities of macrolides against Mycobacterium leprae.

Authors:  S G Franzblau; R C Hastings
Journal:  Antimicrob Agents Chemother       Date:  1988-12       Impact factor: 5.191

6.  Structure-activity relationships of selected phenazines against Mycobacterium leprae in vitro.

Authors:  S G Franzblau; J F O'Sullivan
Journal:  Antimicrob Agents Chemother       Date:  1988-10       Impact factor: 5.191

Review 7.  Leprosy.

Authors:  R C Hastings; T P Gillis; J L Krahenbuhl; S G Franzblau
Journal:  Clin Microbiol Rev       Date:  1988-07       Impact factor: 26.132

8.  In vitro effects of antimicrobial agents on Mycobacterium leprae in mouse peritoneal macrophages.

Authors:  N Ramasesh; J L Krahenbuhl; R C Hastings
Journal:  Antimicrob Agents Chemother       Date:  1989-05       Impact factor: 5.191

9.  In vitro activities of aminoglycosides, lincosamides, and rifamycins against Mycobacterium leprae.

Authors:  S G Franzblau
Journal:  Antimicrob Agents Chemother       Date:  1991-06       Impact factor: 5.191

10.  Phospholipase activity of Mycobacterium leprae harvested from experimentally infected armadillo tissue.

Authors:  P R Wheeler; C Ratledge
Journal:  Infect Immun       Date:  1991-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.